Premium
The screen for cognitive impairment in psychiatry in patients with borderline personality disorder
Author(s) -
Folesani Federica,
Belvederi Murri Martino,
Biancosino Bruno,
Costa Silvia,
Zerbinati Luigi,
Caruso Rosangela,
Nanni Maria Giulia,
Toffanin Tommaso,
Ferrara Maria,
Purdon Scot E.,
Grassi Luigi
Publication year - 2022
Publication title -
personality and mental health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 22
eISSN - 1932-863X
pISSN - 1932-8621
DOI - 10.1002/pmh.1539
Subject(s) - borderline personality disorder , psychology , cognitive impairment , clinical psychology , cognition , psychiatry , psychotherapist , personality disorders , personality , psychoanalysis
Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients. The Screen for Cognitive Impairment for Psychiatry (SCIP) proved to be reliable in different psychiatric populations, but it has not yet been validated in personality disorders. The purpose of this study is therefore to evaluate its psychometric properties in a sample of 58 BPD patients. The SCIP was validated against the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test A and B (TMT A and B). The receiver operator curve analysis displayed an acceptable convergent validity (total score AUC: 0.78, 95% CI: 0.70–0.86; Se: 75%, Sp: 72%). A cut‐off total score of 80 identified 81% of patients as cognitively impaired. The exploratory factor analysis displayed a one‐factor solution explaining 55.8% of the total variance. The SCIP displayed adequate psychometric properties in BPD and could be integrated in the routine clinical assessment to provide a preliminary evaluation of cognitive features for BPD.